A randomized, double-blinded, non-inferiority clinical trial was conducted in Akhtar Hospital from March to June 2023. Patients with clavicle fractures aged 18 to 60, weighing less than 80 kg and consenting to participate in the study were included. Included patients must have had normal neuromotor and sensory function. Patients treated with narcotics or had a history of alcohol, narcotics, or any addictive drug abuse were excluded. Other exclusion criteria included any contraindication of nerve blocks like local infections, coagulopathy, and any allergy to local anesthetics.
Furthermore, patients with mental disorders, restrictive pulmonary disease, pregnancy, bradycardia (heart rate less than 50), and those who consumed beta blockers were all excluded. A complete history was obtained from each case. All the included individuals underwent a thorough neurological examination.
The Ethics Committee of Shahid Beheshti University of Medical Sciences approved this survey (code: IR.SBMU.MSP.REC.1401.526, date of registration: 25/01/2023; the Iranian Registry of Clinical Trials. code: IRCT20230204057318N1). The study protocol followed the Declaration of Helsinki. All the included patients were informed about the purpose of the study, and written consent was obtained.
G power software was used to determine the sample size. Based on Ryan et al.’s study (
15), by considering the effect size = 0.54, α = 0.05, and β (Power) = 0.90, 120 patients for the sample size were chosen for the sample size. Afterward, patients were randomly divided into 2 groups. To ensure fairness, we used computer-generated software to create equal groups through a randomized method. An assistant who was not associated with this study was responsible for generating and managing a random sequence. The randomization code was placed in a sealed opaque envelope by the assistant. A total of 120 cards were selected, with 60 cards in each group. The cards were placed in sealed opaque envelopes and shuffled. Patients selected envelopes without knowledge of the contents. Only those responsible for the randomization process knew which cards were in each envelope, while other members of the research team were kept unaware. After enrolling a patient in the study, an anesthesiologist opened the sealed envelope and proceeded with the allocated procedure. To prevent accidental revelation of allocation to the participants, the block needle is introduced through the same area for both interventions. Additionally, the ultrasound monitor was not within the participant's line of sight. After the procedures, the researcher who assessed the outcome was unaware of the randomization. In case of serious adverse events that could potentially harm the participants, the patients were immediately removed from the trial. The blinding was also removed, and the events were reported. Additionally, the data analyst was also kept unaware of the randomization process.
In the block room, all patients underwent standard monitoring (pulse oximetry, noninvasive blood pressure, and electrocardiogram). In the first group, after placing patients in a supine position with a 30° head-up and dis-infecting the neck with povidone-iodine, ISB was performed by a single anesthesiologist who is an expert in RA (
Figure 2).
Sonography of the brachial plexus, middle scalene muscle, and anterior scalene muscle. The b and a are before and after the injection, respectively (Abbreviations: MSM, middle scalene muscle; ASM, anterior scalene muscle).
Initially, the brachial plexus was identified between the anterior and middle scalene muscles. Then, via ultrasound visualization, a needle was inserted from lateral to medial into the interscalene grove between the nerve roots. Consequently, 20 mL of 1.5% lidocaine (Caspin Company), 1 mL of 8.4% bicarbonate (Caspin Company), 1: 200 000 epinephrine (Daroupakhsh Company), and 4 mL of 0.5% bupivacaine (AstraZeneca Company) were used.
In addition to the mentioned ISB method, SCPB was performed. The high-frequency linear ultrasound probe was slid to the lateral side of the neck at the midpoint of the sternocleidomastoid (SCM) muscle, corresponding to the C6 transverse apophysis and its anterior tubercle at the level of the cricoid cartilage. After identifying the muscle, the probe was moved backward until the posterior edge of the muscle was found. The interscalene groove between the anterior and middle scalene muscles was then identified. Next, SCP was located just above the prevertebral fascia that covers the interscalene groove enclosed within the interstitial space, separating the cervical fascia and the posterior sheath of SCM. A block needle was then introduced from lateral to medial using the posterior-in-plane technique till its tip was placed near the SCP above the prevertebral fascia. After careful negative aspiration to exclude intravascular placement, 10 mL of 1.5% lidocaine (Caspin Company), 1 mL of 8.4% bicarbonate (Caspin Company), 1: 200 000 epinephrine (Daroupakhsh Company), and 4 mL of 0.5% bupivacaine (AstraZeneca Company) were deposited (
Figure 3).
The sternocleidomastoid, internal jugular vein, carotid artery, transverse process, and needle. The A and B are before and after the injection, respectively (Abbreviations: SCM, sternocleidomastoid; IJV, internal jugular vein; CA, carotid artery; TP, transverse process; N, needle).
In both groups, nerve blocks were performed by a single anesthesiologist who is an expert in RA under an ultrasonographic guide (S-Nerve ultrasound Sonosite machine) with a linear transducer with 6 - 15 MHz frequency using the in-plane method with a block needle (B. Braun needle, 22Ga, 80 mm, Stimuplex Ultra 360).
All common challenges of nerve blocks, such as nerve injury, vascular injury, local anesthesia toxicity, and the absence of neurological lesions and neurological evaluation after nerve blocks, were considered for safety considerations.
Loss of shoulder abduction was used to identify motor blockade, while the pinprick test and palpitation were used to determine sensory blockade at the operation site. Also, the arm mobilized passively to assess further pain. A block was deemed successful if all the examinations, as mentioned earlier, were present. If uncontrolled pain occurred after starting surgery that required conversion to GA, the block was considered incompetence.
In the case of patient anxiety, 2 mg of midazolam was administered, and if a patient complained of pain, 50 μg of fentanyl was administered intravenously. If adverse reactions, like bradypnea (respiratory rate less than 8), apnea of more than 15 s, and oxygen saturation of less than 94%, were observed, the process was held, and patients' respiration was aided. At the end of the operation, patients were transferred to the postanesthesia care unit (PACU).
Our primary goal was to compare the need for inducing GA for the operation between intervention and control groups. The secondary outcomes included the requirement for sedation during surgery, comparing postoperative Visual Analog Scale (VAS) scores, and the amount of narcotics used in the PACU between the 2 groups.
Demographic data, the duration of surgery, the beginning of the nerve block, the surgery initiation time, the amount of required sedation during surgery, and the amount of required analgesics in the PACU (meperidine) were all thoroughly recorded. The meperidine was used in fixed doses of 20 mg, repeated every 5 min to achieve adequate response. We also evaluated the pain experienced by patients after the VAS operation in the PACU. All included individuals were followed up until their discharge from the PACU.
The group-matching method was used to omit the confounders. Selection, performance, and detection biases were all omitted by randomization and blinding, respectively. We reported all the significant and insignificant findings of the study. The results were reported completely and clearly. Initially, 7 patients did not consent to receive RA, but no patient was lost during follow-up. To minimize the random error, the sample size was carefully determined prior to the study.
To remove the biases from the randomization process, the allocation was random, and the allocation sequences were concealed. Patients were unaware of the allocation. The main researchers and the expert regional anesthesiologist were the only people who were aware of randomization. The data of all included cases were available, and we had no missing data. Furthermore, the method of measurement was the same in both groups, and the outcome assessor was not aware of allocation. Afterward, data were completely gathered, and all of them were transferred to a blinded data analyst.
The statistical analysis was conducted using SPSS version 26. Descriptive analysis and Students' t-tests were performed. The Mann-Whitney U test was conducted to compare non-parametric variables between the 2 groups. P values less than 0.05 were considered statistically significant.